Status:
COMPLETED
Efficacy and Safety of Moxonidine in Indian Patients
Lead Sponsor:
Solvay Pharmaceuticals
Conditions:
Hypertension
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
The purpose of this study is to demonstrate efficacy and safety of Moxonidine in Indian subjects.
Eligibility Criteria
Inclusion
- Hypertension
Exclusion
- Severe concomitant diseases, CHF, secondary hypertension, severe hypertension, significant hepatic disease, unstable angina
Key Trial Info
Start Date :
July 1 2005
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT00160277
Start Date
July 1 2005
Last Update
January 30 2009
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Site 1
Jubillee Hills Hyderabad, India
2
Site 2
Mangalore, India
3
Site 3
New Delhi, India